Organ Equivalent Dose (mSv/MBq) for α Relative Biological Effectiveness (Weighting Factor) = 3.0
| Target organ | Patient 1 | Patient 2 | Patient 3 | Average |
| Adrenals | 1.13E−01 | 5.64E−01 | 1.32E−02 | 2.30E−01 |
| Brain | 1.09E−01 | 5.58E−01 | 6.98E−03 | 2.25E−01 |
| Breasts | 1.09E−01 | 5.59E−01 | 7.60E−03 | 2.25E−01 |
| Gallbladder wall | 1.32E−01 | 5.87E−01 | 3.99E−02 | 2.53E−01 |
| Lower large intestine wall | 1.41E−01 | 5.99E−01 | 5.43E−02 | 2.65E−01 |
| Small intestine | 1.14E+00 | 6.39E−01 | 1.01E−01 | 6.27E−01 |
| Stomach wall | 1.20E−01 | 5.73E−01 | 2.36E−02 | 2.39E−01 |
| Upper large intestine wall | 1.86E−01 | 6.48E−01 | 1.12E−01 | 3.15E−01 |
| Heart wall | 1.10E−01 | 5.60E−01 | 8.78E−03 | 2.26E−01 |
| Kidneys | 1.20E−01 | 5.72E−01 | 2.32E−02 | 2.38E−01 |
| Liver | 1.15E−01 | 5.66E−01 | 1.58E−02 | 2.32E−01 |
| Lungs | 1.09E−01 | 5.59E−01 | 8.39E−03 | 2.25E−01 |
| Muscle | 1.15E−01 | 5.65E−01 | 1.53E−02 | 2.32E−01 |
| Ovaries | 1.59E−01 | 6.18E−01 | 7.64E−02 | 2.84E−01 |
| Pancreas | 1.16E−01 | 5.68E−01 | 1.82E−02 | 2.34E−01 |
| Peritoneal fluid | 1.89E+02 | 3.52E+02 | 2.07E+02 | 2.49E+02 |
| Red marrow | 9.32E−02 | 4.42E−01 | 1.79E−02 | 1.84E−01 |
| Osteogenic cells | 3.86E−01 | 2.08E+00 | 3.51E−02 | 8.34E−01 |
| Skin | 1.10E−01 | 5.60E−01 | 9.31E−03 | 2.26E−01 |
| Spleen | 1.14E−01 | 5.65E−01 | 1.51E−02 | 2.31E−01 |
| Thymus | 1.09E−01 | 5.59E−01 | 7.50E−03 | 2.25E−01 |
| Thyroid | 1.09E−01 | 5.58E−01 | 7.06E−03 | 2.25E−01 |
| Urinary bladder wall | 1.20E−01 | 5.73E−01 | 2.43E−02 | 2.39E−01 |
| Uterus | 1.54E−01 | 6.10E−01 | 6.78E−02 | 2.77E−01 |
| Total body | 2.54E+00 | 4.89E+00 | 5.57E+00 | 4.33E+00 |